Pressure Financial Statements From 2010 to 2024

PBIODelisted Stock  USD 0.49  0.00  0.00%   
Pressure Biosciences financial statements provide useful quarterly and yearly information to potential Pressure Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Pressure Biosciences financial statements helps investors assess Pressure Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Pressure Biosciences' valuation are summarized below:
Pressure Biosciences does not presently have any trending fundamental ratios for analysis.
Check Pressure Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pressure Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Pressure financial statements analysis is a perfect complement when working with Pressure Biosciences Valuation or Volatility modules.
  
This module can also supplement various Pressure Biosciences Technical models . Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Pressure Biosciences OTC Stock Return On Asset Analysis

Pressure Biosciences' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Pressure Biosciences Return On Asset

    
  -0.93  
Most of Pressure Biosciences' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pressure Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Pressure Biosciences has a Return On Asset of -0.9258. This is 89.42% lower than that of the Life Sciences Tools & Services sector and 94.89% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.

Pressure Biosciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Pressure Biosciences's current stock value. Our valuation model uses many indicators to compare Pressure Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pressure Biosciences competition to find correlations between indicators driving Pressure Biosciences's intrinsic value. More Info.
Pressure Biosciences is rated below average in return on asset category among its peers. It is regarded fifth in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pressure Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pressure Biosciences' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Pressure Biosciences Financial Statements

Pressure Biosciences investors utilize fundamental indicators, such as revenue or net income, to predict how Pressure OTC Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp. Pressure Biosciences operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 12 people.

Pair Trading with Pressure Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pressure Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pressure Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Pressure OTC Stock

  0.63VERO Venus ConceptPairCorr
  0.77DYNT DynatronicsPairCorr

Moving against Pressure OTC Stock

  0.88ELMD ElectromedPairCorr
  0.87MYO Myomo IncPairCorr
  0.86BSX Boston Scientific CorpPairCorr
  0.85PEN PenumbraPairCorr
  0.84OM Outset MedicalPairCorr
The ability to find closely correlated positions to Pressure Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pressure Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pressure Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pressure Biosciences to buy it.
The correlation of Pressure Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pressure Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pressure Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pressure Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Pressure OTC Stock

If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamental Analysis
View fundamental data based on most recent published financial statements
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity